AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28198032 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 32
Study 23266232 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational Atherectomy (RA) followed by stenting
Number of subjects: 240
Study 23266232 — intervention group
Group type: COMPARATOR
Intervention: Stenting without RA (standard therapy group)
Number of subjects: 240
Study 23266232 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 240
Study 21494052 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulimia Nervosa Patients
Number of subjects: 75
Study 21494052 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 75
Study 18222382 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater social network size
Number of subjects: 605
Study 18222382 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller social network size
Number of subjects: 605
Study 16459509 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching health education combined with leaflet and drama methods
Number of subjects: 1005
Study 16459509 — intervention group
Group type: COMPARATOR
Intervention: Leaflet-only group
Number of subjects: 1005
Study 12638098 — intervention group
Group type: EXPERIMENTAL
Intervention: Active left limb movement (button push; n=3)
Number of subjects: 9
Study 12638098 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive left limb movement with functional electric stimulation (FES; n=8)
Number of subjects: 9
Study 10229295 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg daily
Number of subjects: 20
Study 10229295 — intervention group
Group type: COMPARATOR
Intervention: Hydrene (triamterene 50 mg with hydrochlorothiazide 25 mg) daily
Number of subjects: 20
Study 10158542 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 200000
Study 10158542 — intervention group
Group type: COMPARATOR
Intervention: Non-hysterectomy treatment
Number of subjects: 200000
Study 1878335 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 40 mg slow-release b.i.d.
Number of subjects: 28
Study 1878335 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg slow-release b.i.d.
Number of subjects: 28
Study 1878335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 6130842 — intervention group
Group type: EXPERIMENTAL
Intervention: Quazepam 15 mg/night
Number of subjects: 60
Study 6130842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31091527 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 110
Study 27545509 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3/6 capsules (three capsules twice daily)
Number of subjects: 154
Study 27545509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 27533157 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide, 80 μg
Number of subjects: 2463
Study 27533157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2463
Study 27533157 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide, 20 μg
Number of subjects: 2463
Study 24710994 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored interactive multimedia computer program (IMCP)
Number of subjects: 867
Study 24710994 — intervention group
Group type: COMPARATOR
Intervention: Attention control (sleep hygiene video)
Number of subjects: 867
Study 24710994 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted depression public service announcement (PSA) video
Number of subjects: 867
Study 23113962 — intervention group
Group type: EXPERIMENTAL
Intervention: CT slice interval of 1.25 mm
Number of subjects: 30
Study 23113962 — intervention group
Group type: EXPERIMENTAL
Intervention: CT slice interval of 2.5 mm
Number of subjects: 30
Study 23113962 — intervention group
Group type: COMPARATOR
Intervention: CT slice interval of 5 mm
Number of subjects: 30
Study 19452124 — intervention group
Group type: EXPERIMENTAL
Intervention: AS extract (3 g per day) plus calcium (500 mg per day)
Number of subjects: 81
Study 19452124 — intervention group
Group type: COMPARATOR
Intervention: Calcium (500 mg per day)
Number of subjects: 81
Study 17465977 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil 0.5 mg intravenously
Number of subjects: 82
Study 17465977 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.7 mg/kg intravenously
Number of subjects: 82
Study 15143082 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC therapy (vincristine, dactinomycin, and cyclophosphamide)
Number of subjects: 339
Study 15143082 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC therapy with concomitant abdominal radiotherapy
Number of subjects: 339
Study 15143082 — intervention group
Group type: COMPARATOR
Intervention: Control group (VAC alternating with vincristine, topotecan, and cyclophosphamide)
Number of subjects: 339
Study 11166149 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological Distress Inventory and Hospital Anxiety and Depression Scale administered before and during chemotherapy, and at the first follow‐up visit.
Number of subjects: 132
Study 11166149 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression including clinical and demographic variables (age, psychiatric history).
Number of subjects: 132
Study 11166149 — intervention group
Group type: EXPERIMENTAL
Intervention: Two questionnaires (Psychological Distress Inventory and Hospital Anxiety and Depression Scale).
Number of subjects: 132
Study 11166149 — intervention group
Group type: EXPERIMENTAL
Intervention: Three predictive models developed for each evaluation point including age, psychiatric history, and psychological distress.
Number of subjects: 132
Study 9749820 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed method (experimental group)
Number of subjects: 98
Study 9749820 — intervention group
Group type: COMPARATOR
Intervention: Faculty-assisted method (control group)
Number of subjects: 98
Study 7868849 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 149
Study 7868849 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 149
Study 7868849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 3349432 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant combination chemotherapy
Number of subjects: 290
Study 3349432 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy alone
Number of subjects: 290
Study 3349432 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tumor burden, histologic subtype, and sex
Number of subjects: 290
Study 3349432 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor burden and age
Number of subjects: 290
Study 30676196 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 g of whey protein combined with resistance training
Number of subjects: 30
Study 30676196 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with resistance training
Number of subjects: 30
Study 28632587 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-navigated knee arthroplasty
Number of subjects: 162
Study 28632587 — intervention group
Group type: COMPARATOR
Intervention: Conventional knee arthroplasty
Number of subjects: 162
Study 25921846 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols during the four-year follow-up
Number of subjects: 340
Study 25921846 — intervention group
Group type: EXPERIMENTAL
Intervention: Lathosterol levels
Number of subjects: 340
Study 25921846 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of rs4299376 and study group
Number of subjects: 340
Study 23032071 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 74
Study 23032071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 21775748 — intervention group
Group type: EXPERIMENTAL
Intervention: Project Dulce peer intervention
Number of subjects: 207
Study 21775748 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes care
Number of subjects: 207
Study 19835725 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel alone
Number of subjects: 260
Study 19835725 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel plus SLS
Number of subjects: 260
Study 19835725 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 260
Study 16522914 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg Ca/d (as calcium carbonate)
Number of subjects: 125
Study 16522914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 12536052 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate sodium infused at 3.0 mg/kg/min
Number of subjects: 112
Study 12536052 — intervention group
Group type: COMPARATOR
Intervention: Valproate sodium infused at 1.5 mg/kg/min
Number of subjects: 112
Study 11114135 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 84
Study 11114135 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump-prime-only aprotinin
Number of subjects: 84
Study 11114135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 8657237 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1829
Study 8657237 — intervention group
Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 1829
Study 8657237 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG (diabetic subgroup)
Number of subjects: 1829
Study 8657237 — intervention group
Group type: COMPARATOR
Intervention: PTCA (diabetic subgroup)
Number of subjects: 1829
Study 2058821 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled infusion of propofol and ketamine
Number of subjects: 20
Study 2058821 — intervention group
Group type: COMPARATOR
Intervention: Simple administration regimen of propofol and ketamine
Number of subjects: 20
Study 2058821 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 6439019 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (NTG‐TTS), 5 mg/24 hr
Number of subjects: 11
Study 6439019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31244356 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate + IFX therapy
Number of subjects: 128
Study 31842529 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 90
Study 31842529 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 90
Study 28088187 — intervention group
Group type: COMPARATOR
Intervention: Oral ergocalciferol plus placebo (n = 36)
Number of subjects: 68
Study 28088187 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ergocalciferol plus calcitriol (n = 32)
Number of subjects: 68
Study 28088187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study 25996459 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung age intervention (lung age determination, education, and smoking cessation advice)
Number of subjects: 108
Study 25996459 — intervention group
Group type: COMPARATOR
Intervention: Usual smoking education (control group)
Number of subjects: 108
Study 23575309 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT) for 21 hours
Number of subjects: 38
Study 23575309 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 38
Study 21102493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac (60 mg) before surgery
Number of subjects: 67
Study 21102493 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline (control group)
Number of subjects: 67
Study 19579920 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mcg misoprostol placed in posterior fornix of case group
Number of subjects: 66
Study 19579920 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet in control group
Number of subjects: 66
Study 16907704 — intervention group
Group type: EXPERIMENTAL
Intervention: Common single nucleotide polymorphisms (SNPs) in 9 innate immunity genes (CARD15, IRAK1, IRAK4, LBP, LY86, MEFV, TLR2, TLR4, NFKB1)
Number of subjects: 717
Study 16907704 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-synonymous SNPs in TLR4 and CARD15
Number of subjects: 717
Study 14967547 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive remediation training in addition to work therapy
Number of subjects: 94
Study 14967547 — intervention group
Group type: COMPARATOR
Intervention: Work therapy only
Number of subjects: 94
Study 11438853 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary caregivers of spinal cord injury survivors
Number of subjects: 50
Study 11438853 — intervention group
Group type: COMPARATOR
Intervention: Healthy age-matched controls
Number of subjects: 50
Study 9924327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide/timolol combination solution administered twice daily (Cosopt)
Number of subjects: 299
Study 9924327 — intervention group
Group type: COMPARATOR
Intervention: Dorzolamide solution twice daily plus timolol maleate solution twice daily (concomitant)
Number of subjects: 299
Study 9924327 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (combination and concomitant)
Number of subjects: 299
Study 7816415 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative administration of mitomycin C (4% solution, applied for 3 min)
Number of subjects: 30
Study 7816415 — intervention group
Group type: COMPARATOR
Intervention: Surgical excision only (control group)
Number of subjects: 30
Study 3290427 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanguinarine-containing dentifrice (750 mcg/g)
Number of subjects: 120
Study 3290427 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice (similar composition without sanguinarine)
Number of subjects: 120
Study 30627178 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 22
Study 30627178 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 28679366 — intervention group
Group type: EXPERIMENTAL
Intervention: Small scaled homelike SCU
Number of subjects: 145
Study 28679366 — intervention group
Group type: COMPARATOR
Intervention: Regular SCU
Number of subjects: 145
Study 25794212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (bolus 1.5 mg/kg at induction, then infusion at 2 mg/kg/hr, up to 2 hours after surgery)
Number of subjects: 61
Study 25794212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 23462886 — intervention group
Group type: EXPERIMENTAL
Intervention: MSDC-0160 (50, 100, or 150 mg)
Number of subjects: 258
Study 23462886 — intervention group
Group type: EXPERIMENTAL
Intervention: MSDC-0160 (higher doses)
Number of subjects: 258
Study 23462886 — intervention group
Group type: EXPERIMENTAL
Intervention: MSDC-0160
Number of subjects: 258
Study 23462886 — intervention group
Group type: COMPARATOR
Intervention: pioglitazone (45 mg)
Number of subjects: 258
Study 23462886 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 258
Study 21672053 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose CYT003-QbG10
Number of subjects: 299
Study 21672053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 18266655 — intervention group
Group type: EXPERIMENTAL
Intervention: Excite DSC/Variolink II without silanization (Group A1)
Number of subjects: 40
Study 18266655 — intervention group
Group type: EXPERIMENTAL
Intervention: Excite DSC/Variolink II with silanization (Group A2)
Number of subjects: 40
Study 18266655 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond MPP/RelyX ARC without silanization (Group B1)
Number of subjects: 40
Study 18266655 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond MPP/RelyX ARC with silanization (Group B2)
Number of subjects: 40
Study 17458083 — intervention group
Group type: EXPERIMENTAL
Intervention: Corsodyl gel + surgical dressing
Number of subjects: 40
Study 17458083 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling
Number of subjects: 40
Study 17458083 — intervention group
Group type: COMPARATOR
Intervention: Corsodyl rinse
Number of subjects: 40
Study 17458083 — intervention group
Group type: COMPARATOR
Intervention: Corsodyl gel
Number of subjects: 40
Study 12776809 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-LOT (30 mg coumarin and 180 mg troxerutin t.i.d.)
Number of subjects: 231
Study 12776809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 12776809 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-LOT
Number of subjects: 231
Study 10867429 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 18
Study 10867429 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidulated phosphate fluoride (APF) group
Number of subjects: 18
Study 10867429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicalcium phosphate dihydrate (DCPD) - APF group
Number of subjects: 18
Study 9413801 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal book intervention (N = 30)
Number of subjects: 90
Study 9413801 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal book + three video-feedback sessions (N = 30)
Number of subjects: 90
Study 9413801 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 30)
Number of subjects: 90
Study 1590289 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate
Number of subjects: 23
Study 1590289 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 23
Study 7267676 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 6
Study 7267676 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid
Number of subjects: 6
Study 7267676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31438960 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Health Record (EHR) implementation in community mental health clinics
Number of subjects: 5
Study 31438960 — intervention group
Group type: COMPARATOR
Intervention: EHRs in different stages of development
Number of subjects: 5
Study 31438960 — intervention group
Group type: COMPARATOR
Intervention: Qualitative data from focus groups and interviews
Number of subjects: 5
Study 28122335 — intervention group
Group type: EXPERIMENTAL
Intervention: PS detection in patient plasma using a highly stringent ELISA
Number of subjects: 44
Study 25573500 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion-mode (MM) echography
Number of subjects: 50
Study 25573500 — intervention group
Group type: COMPARATOR
Intervention: Anatomical motion-mode (AMM) echography
Number of subjects: 50
Study 24229770 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 50
Study 24229770 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 50
Study 21397519 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo acupuncture
Number of subjects: 6
Study 19637354 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-screen (annual chest X-ray and 4-monthly sputum cytology)
Number of subjects: 20426
Study 19637354 — intervention group
Group type: COMPARATOR
Intervention: X-ray only arm
Number of subjects: 20426
Study 17377048 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction increment of 3.0 mm (Group A)
Number of subjects: 40
Study 17377048 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction increment of 1.5 mm (Group A)
Number of subjects: 40
Study 17377048 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction increment of 3.0 mm (Group B)
Number of subjects: 40
Study 17377048 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction increment of 1.5 mm (Group B)
Number of subjects: 40
Study 16982395 — intervention group
Group type: EXPERIMENTAL
Intervention: Using a condom
Number of subjects: 418
Study 16982395 — intervention group
Group type: COMPARATOR
Intervention: Not using a condom
Number of subjects: 418
Study 16982395 — intervention group
Group type: EXPERIMENTAL
Intervention: Having sex
Number of subjects: 418
Study 12960598 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental nitroglycerin infusion (NTG+Inf)
Number of subjects: 50
Study 12960598 — intervention group
Group type: COMPARATOR
Intervention: Resting TF imaging without NTG+Inf
Number of subjects: 50
Study 10522281 — intervention group
Group type: EXPERIMENTAL
Intervention: Practiced without visual restrictions before transferring to full vision
Number of subjects: 0
Study 10522281 — intervention group
Group type: EXPERIMENTAL
Intervention: Practiced with visual restrictions before transferring to full vision
Number of subjects: 0
Study 10522281 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 7567309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftibuten (9 mg/kg once daily for 10 days)
Number of subjects: 426
Study 7567309 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V (25 mg/kg/day in 3 divided doses for 10 days)
Number of subjects: 426
Study 7567309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftibuten and Penicillin V
Number of subjects: 426
Study 2174492 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of delta-9-tetrahydrocannabinol (THC) followed by 3.2 mg flumazenil
Number of subjects: 15
Study 2174492 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of delta-9-tetrahydrocannabinol (THC) followed by 3.2 mg flumazenil
Number of subjects: 15
Study 2174492 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of delta-9-tetrahydrocannabinol (THC) followed by 6.4 mg flumazenil
Number of subjects: 15
Study 2174492 — intervention group
Group type: COMPARATOR
Intervention: Placebo after THC
Number of subjects: 15
Study 7019406 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure of the PDA using indomethacin (mean = 48.8 hours)
Number of subjects: 24
Study 7019406 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical management (intervention only after cardiopulmonary decompensation, mean = 167.4 hours)
Number of subjects: 24
Study 7019406 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure of the PDA using indomethacin
Number of subjects: 24
Study 30632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 167
Study 30632922 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic Therapy (PDT)
Number of subjects: 167